- Home
- HITI vs AMRN Comparison
HITI vs AMRN Comparison
Compare HITI & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HITI
- AMRN
- Stock Information
- Founded
- HITI 2009
- AMRN 1989
- Country
- HITI Canada
- AMRN Ireland
- Employees
- HITI N/A
- AMRN N/A
- Industry
- HITI
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- HITI
- AMRN Health Care
- Exchange
- HITI Nasdaq
- AMRN Nasdaq
- Market Cap
- HITI 187.8M
- AMRN 216.0M
- IPO Year
- HITI N/A
- AMRN 1993
- Fundamental
- Price
- HITI $2.45
- AMRN $15.85
- Analyst Decision
- HITI Strong Buy
- AMRN Strong Sell
- Analyst Count
- HITI 2
- AMRN 1
- Target Price
- HITI $4.75
- AMRN $12.00
- AVG Volume (30 Days)
- HITI 296.5K
- AMRN 171.2K
- Earning Date
- HITI 09-15-2025
- AMRN 07-30-2025
- Dividend Yield
- HITI N/A
- AMRN N/A
- EPS Growth
- HITI N/A
- AMRN N/A
- EPS
- HITI N/A
- AMRN N/A
- Revenue
- HITI $398,202,371.00
- AMRN $214,112,000.00
- Revenue This Year
- HITI $12.43
- AMRN N/A
- Revenue Next Year
- HITI $11.39
- AMRN N/A
- P/E Ratio
- HITI N/A
- AMRN N/A
- Revenue Growth
- HITI 9.22
- AMRN N/A
- 52 Week Low
- HITI $1.57
- AMRN $7.08
- 52 Week High
- HITI $3.62
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- HITI 62.47
- AMRN 58.98
- Support Level
- HITI $2.29
- AMRN $15.43
- Resistance Level
- HITI $2.52
- AMRN $16.21
- Average True Range (ATR)
- HITI 0.09
- AMRN 0.68
- MACD
- HITI 0.02
- AMRN -0.25
- Stochastic Oscillator
- HITI 86.21
- AMRN 30.10
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.